This includes activating other immune cells, like macrophages, B cells, and cytotoxic CD8+ T lymphocytes (CTL), promoting the targeted killing of infected cells, tumour cells, and abnormal cells, as well as inducing cell lysis and other effector functions. Here, CD8A is linked to neoplasm.